Does anxiety moderate the effectiveness of mirtazapine in patients with treatment-resistant depression? A secondary analysis of the MIR trial

BACKGROUND: There is a lack of evidence to guide treatment of comorbid depression and anxiety. Preliminary evidence suggests mirtazapine may be effective in treating patients with both depression and anxiety symptoms. METHODS: We undertook a secondary analysis of mirtazapine (MIR): a placebo-control...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Psychopharmacol
Glavni autori: Rifkin-Zybutz, Raphael, MacNeill, Stephanie, Davies, Simon JC, Dickens, Christopher, Campbell, John, Anderson, Ian M, Chew-Graham, Carolyn A, Peters, Tim J, Lewis, Glyn, Wiles, Nicola, Kessler, David
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2020
Teme:
Original Papers
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7708671/
https://ncbi.nlm.nih.gov/pubmed/33143538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0269881120965939
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items